Medical Technology and Devices businesses are facing long and capital-intensive product development cycles, complex regulatory procedures, slow market uptake requiring the support of key opinion leaders and intensive follow-up with early adopters. In addition to a mature technology, a well thought-out and realistic exploitation path with emphasis on achieving market  traction as proof of both clinical and market potential of the idea is needed.

Proposal submitted to this transition challenge call should aim to:

• Perform the necessary research and development to advance from an existing proof-of-principle technology to a mature version to initiate clinical evaluation.
• Develop an exploitation strategy, qualitatively and quantitatively outlining the proposed path to patient and describing an investable proposition.

Proposals can target any technology addressing important health needs in the direct clinical treatment and care of patients, such as infectious and respiratory disease management, brain or nerve monitoring and stimulation technologies, high-tech endoscopes and smart catheters, surgical robots, perinatal support technology, radically portable dialysis, artificial pancreas for diabetes control, minimally invasive heart surgery, portable PET and MRI, drug delivery/eluting biomaterials, point-of-care non-invasive screening devices, etc.

The EU contribution can reach up to EUR 2.5 million and the duration of the project up to 3 years.